Merck & Company
(MRK)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2019 | 12-2018 | 12-2017 | 12-2016 | 12-2015 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 5,606,000 | 6,193,000 | 2,418,000 | 3,941,000 | 4,459,000 |
| Depreciation Amortization | 3,310,000 | 4,519,000 | 4,676,000 | 5,471,000 | 6,375,000 |
| Income taxes - deferred | -560,000 | -509,000 | -2,621,000 | -1,521,000 | -764,000 |
| Accounts receivable | 92,000 | -418,000 | 297,000 | -619,000 | -480,000 |
| Accounts payable and accrued liabilities | 443,000 | 230,000 | 254,000 | 278,000 | -37,000 |
| Other Working Capital | -2,077,000 | -1,553,000 | -5,017,000 | -2,601,000 | -268,000 |
| Other Operating Activity | 2,070,000 | 2,460,000 | 6,444,000 | 5,427,000 | 3,253,000 |
| Operating Cash Flow | $8,884,000 | $10,922,000 | $6,451,000 | $10,376,000 | $12,538,000 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 5,420,000 | 7,258,000 | 4,925,000 | -1,298,000 | 3,732,000 |
| PPE Investments | -3,369,000 | -2,615,000 | -1,888,000 | -1,614,000 | -1,283,000 |
| Net Acquisitions | -4,954,000 | -431,000 | -396,000 | -780,000 | -7,428,000 |
| Other Investing Activity | 374,000 | 102,000 | 38,000 | 482,000 | 221,000 |
| Investing Cash Flow | $-2,529,000 | $4,314,000 | $2,679,000 | $-3,210,000 | $-4,758,000 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | -3,710,000 | 5,124,000 | -26,000 | 0 | -1,540,000 |
| Debt Issued | 4,958,000 | N/A | N/A | 1,079,000 | 7,938,000 |
| Debt Repayment | N/A | -4,287,000 | -1,103,000 | -2,386,000 | -2,906,000 |
| Common Stock Issued | 361,000 | 591,000 | 499,000 | 939,000 | 485,000 |
| Common Stock Repurchased | -4,780,000 | -9,091,000 | -4,014,000 | -3,434,000 | -4,186,000 |
| Dividend Paid | -5,695,000 | -5,172,000 | -5,167,000 | -5,124,000 | -5,117,000 |
| Other Financing Activity | 5,000 | -325,000 | -195,000 | -118,000 | -61,000 |
| Financing Cash Flow | $-8,861,000 | $-13,160,000 | $-10,006,000 | $-9,044,000 | $-5,387,000 |
| Exchange Rate Effect | 17,000 | -205,000 | 457,000 | -131,000 | -1,310,000 |
| Beginning Cash Position | 7,967,000 | 6,096,000 | 6,515,000 | 8,524,000 | 7,441,000 |
| End Cash Position | 9,934,000 | 7,967,000 | 6,096,000 | 6,515,000 | 8,524,000 |
| Net Cash Flow | $1,967,000 | $1,871,000 | $-419,000 | $-2,009,000 | $1,083,000 |
| Free Cash Flow | |||||
| Operating Cash Flow | 8,884,000 | 10,922,000 | 6,451,000 | 10,376,000 | 12,538,000 |
| Capital Expenditure | -3,369,000 | -2,615,000 | -1,888,000 | -1,614,000 | -1,283,000 |
| Free Cash Flow | 5,515,000 | 8,307,000 | 4,563,000 | 8,762,000 | 11,255,000 |